Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FR1JP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,881
Award facts
- Contract value 100% obligated
- $3,881.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc. for 200-unit vials of Botox on September 3, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order represents no set-aside designation and will be performed at the contractor's facility in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, serves as the prime contractor on this engagement.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. The IDC, awarded under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support medical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a robust contract portfolio demonstrating consistent success in competing for pharmaceutical delivery orders with federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FR1JP?
SPE2DB25FR1JP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FR1JP worth?
The government has obligated $3,881 on SPE2DB25FR1JP.
Is contract SPE2DB25FR1JP an order under another contract?
Yes. SPE2DB25FR1JP is a delivery order under SPE2DB22D9251, an indefinite delivery contract.
Was contract SPE2DB25FR1JP competed?
The extent of competition for SPE2DB25FR1JP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award